ArticleOncology letters2012

Phase II trial of capecitabine combined with docetaxel in previously treated patients with non-small cell lung cancer: A randomized controlled study.

Qiang Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.